Core mandate Build and validate a capital-efficient U.S. veterinary market-entry path before major USDA or manufacturing investment. Primary responsibilitiesDevelop partnerships with veterinary labs, hospital groups, uni…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Full-time
Posted 6d ago
~40 hrs/week
Remote in San Diego, California, United States
Responsibilities
Build and validate a capital-efficient market-entry path for the U.S. veterinary market through strategic partnerships and pilots. Develop a qualified pipeline of labs, hospital groups, and distributors to validate customer needs and commercial economics.
Requirements
Requires 5-10 years of experience in veterinary diagnostics, animal health, or laboratory services with existing U.S. industry relationships. Candidates must be comfortable with ambiguity and capable of converting discussions into commercial commitments.
Full job description
Core mandate
Build and validate a capital-efficient U.S. veterinary market-entry path before major USDA or manufacturing investment.
Primary responsibilities
Develop partnerships with veterinary labs, hospital groups, universities, KOLs, distributors, and strategic companies.
Build and manage a qualified partner pipeline.
Design and advance pilots, evaluations, white-label, licensing, and reference-lab opportunities.
Founded in 2017, Pluslife is best known for its Palm-Sized Mini Dock Molecular POC System. The technology behind called RHAM, a self-invented and patented nucleic acid isothermal amplification detection technology that is comparable to lab PCR test performances. Driven by RHAM, more products were launched to the market, which included Dock Pro 8 Molecular POC System, HPV 16/18/46 Test, STD CT/NG/UU Test, COVID-19/Flu A/Flu B Test, etc.
Founded in 2017, Pluslife is best known for its Palm-Sized Mini Dock Molecular POC System. The technology behind called RHAM, a self-invented and patented nucleic acid isothermal amplification detection technology that is comparable to lab PCR test performances. Driven by RHAM, more products were launched to the market, which included Dock Pro 8 Molecular POC System, HPV 16/18/46 Test, STD CT/NG/UU Test, COVID-19/Flu A/Flu B Test, etc.